An interventional study of Lipo-Curcumin gel + SRP and Lipo gel + SRP in Periodontal Diseases, Periodontal Pocket and Periodontal Attachment Loss, sponsored by G. d'Annunzio University. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-02.
Sponsored by G. d'Annunzio University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Periodontal Diseases with a site in Italy — 18 open to participants now, 20 under way, none of them phase 3. Periodontal Diseases · Italy.
Among the 72 studies in Periodontal Diseases with a site in Italy, this one is the 14th largest by planned enrollment of the 48 interventional ones that give a count, is one of 6 that started in 2024, is one of 46 with no phase, reaches primary completion later than 5 of the 19 other live ones, and was the 56th registered.
871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.
Browse Periodontal Diseases studies →18 of the 72 studies in Periodontal Diseases with a site in Italy are open now. Recruiting first, the newest first:
University of Turin, Italy · Sites in Italy
Ages 18–60
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Sites in Italy, China, United Kingdom
Ages 18+ · Healthy volunteers
University of Bologna · Sites in Italy
Ages 18+ · Healthy volunteers
University of Roma La Sapienza · Sites in Italy
Ages 18+ · Healthy volunteers
University of Pavia · Sites in Italy
Ages 18–45 · Women only
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 6 started in 2024.
This study's planned enrollment of 40 is below the median of 45 across 559 interventional studies indexed under Periodontal Diseases.
Median enrollment 40 across the 48 interventional studies, 126 across the 24 observational. Of the 45 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 72 have an industry lead sponsor. The 10 most frequent:
G. d'Annunzio University is the lead sponsor of 68 studies on the registry; 22 are open to participants now.
G. d'Annunzio University has 4 studies filed under Periodontal Diseases — fewer than ten, so there is no comparison to draw.
3 of the studies in Periodontal Diseases with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07604493University of Roma La SapienzaOral Health and Systemic Diseases: Survey of General Practitioners | 2026-11-30 |
| NCT07725913University of BolognaThermosensitive Hyaluronic Gel With Octenidine as an Adjunctive to Subgingival Instrumentation | 2027-02-01 |
| NCT07905859University of Turin, ItalyEffects Of Periodontal Therapy In Patients With Inflammatory Bowel Disease | 2027-09-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 72 studies in Periodontal Diseases with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of the present study is to clinically and radiographically compare the effectivness of Scaling and Root Plannig (SRP) in association with lipo-curcumin gel (LC) respect SRP+ lipo-gel (L), SRP+ discharged (D) gel and SRP alone.
This study will be designed as a randomized clinical trial of 12-month duration. A total of 40 patients will be recruited and randomly equally distributed into 4 groups: an experimental group treated with SRP + LC, a first control group treated with SRP + L, a second control group treated with SRP+D and a third control group SRP alone.
Each defect will be treated with an ultrasonic scaler with dedicated thin tips for supra- and subgingival debridement associated with hand instrumentation under local anesthesia. Caution will be taken to preserve the stability of soft tissues. Following SRP, experimental and control sites will be randomly chosen. The test sites will be t filled with a Lipo-Curcumin gel and sealed with cyanoacrylate. In the first control group the defects will be be filled with a Lipo gel and sealed with cyanoacrylate. In the second control sites he pocket defect will be filled with a discharged gel and sealed with cyanoacrylate, in the third control group SRP alone will be performed.
Pre- and post-treatment clinical measurements were performed by an examiner blinded to the treatment modalities using a graded periodontal probe (HuFriedy UNC 15). Before the treatment and at 6 and 12 months post-treatment, all patients were examined by measuring the clinical attachment level, probing depth, gingival recession, full-mouth plaque score and bleeding on probing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After SRP the pocket defect will be filled with a Lipo-Curcumin gel and sealed with cyanoacrylate.
Procedure: Lipo-Curcumin gel + SRP
After SRP the pocket defect will be filled with a Lipo gel and sealed with cyanoacrylate
Procedure: Lipo gel + SRP
After SRP the pocket defect will be filled with a discharged gel and sealed with cyanoacrylate
Procedure: Discharged Gel + SRP
SRP alone will be performed.
Procedure: SRP alone
The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of Lipo- Curcumin gel. The pocket will be sealed with cyanoacrylate.
The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of Lipo gel. The pocket will be sealed with cyanoacrylate.
The pocket defect will be debrided with the use of fine ultrasonic tips and mini hand instruments and will be treated with the application of discharged gel. The pocket will be sealed with cyanoacrylate.
The pocket defect will only be debrided with the use of fine ultrasound tips and mini hand instruments and no further treatment will be performed.
Pocket Probing Depth (PPD)
Distance between the gingival margin and the bottom of the pocket.
Time frame: 12 months
Clinical Attachment Level (CAL)
Distance between the CEJ and the bottom of the pocket
Time frame: 12 months
Gingival Recession (GR)
Distance between the CEJ and the gingival margin.
Time frame: 12 months
Full Mouth Plaque Score
Index that evaluates the general presence of bacterial plaque for all teeth. Through the passage of the probe, the presence of plaque deposits is reported for 4 surfaces for each tooth. A ratio is made between the contaminated surfaces and the total surfaces investigated to obtain a percentage value.
Time frame: 12 months
Full Mouth Bleeding Score
Index that evaluates the general presence of bleeding for all teeth. Through the insertion of a periodontal probe, the presence of bleeding on probing is signaled for 4 sites for each tooth. A ratio is made between the bleeding sites and the total sites investigated to obtain a percentage value.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2024 (actual). Primary completion is estimated for Jun 2025, 12 months after the start.
Of 314 non-industry interventional studies with no phase under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 28. This study's planned 12 months is close to that.
Counting every sponsor, half of 333 studies reached it within 13 months; a quarter within 8 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
G. d'Annunzio University